Health of people from ethnic minority groups

The King's Fund logoThe Kings Fund has produced an explainer on the health of people from ethnic minority groups in England. Whilst this doesn’t include MSK health, it does include several relevant determinants of health including physical activity levels, obesity, healthy diet, socioeconomic inequalities and access to services.

The document concludes that strategies for improving the health of England’s ethnic minority communities need to address the multiple factors that have an impact on their health. It identifies four areas for focus:

  • The role of public health and NHS services
  • Addressing the wider determinants of health
  • Tackling structural racism
  • Data

Read the explainer.

Upcoming NRAS JIA events

Join NRAS for their first JIA Zoom event: Coping with JIA during COVID-19.
This event is exclusively for parents who have children with JIA.
When: Wednesday 10th March, 6:30pm-8pm on Zoom.

There will be an update from Debbie Wilson, NRAS Young Persons Project Co-ordinator, an update from Nick Wilkinson, Paediatric Rheumatologist, and a short talk from one of our Young Voices.

Visit this link to sign up.

In April, loin NRAS for a Zoom event for young people living with JIA:
Navigating your Future with inflammatory arthritis

This event is exclusively for young people aged 16-30.…

Read more of this article

X-Factor star learns about axial SpA

Talia Dean meets Dasha and Gillian to learn more about axial SpA (AS)

Singer-songwriter, Talia Dean, made a big announcement in January 2021. In 2020 she was diagnosed with axial SpA (AS). Watch this video as she meets Dasha and Gillian, who live with the disease, and starts her journey towards becoming an #ASWarrior. #TaliasASJourney

See Talia’s story in the BBC article, 15 January 2021:
My back pain was misdiagnosed for 15 years – now I can’t dance

Welcoming a new member

We are delighted to welcome a new ARMA member, Physio First.

Physio First is a membership trade association of self-employed Chartered physiotherapists. Their organisational statement of intent: to “champion evidenced value based private physiotherapy with Physio First members in the changing healthcare marketplace.”

Read more about Physio Fast on our Membership page.

Proposed Health Index consultation

The Office for National Statistics is consulting on a new measure for health in England, recognising that the nation’s health is an asset – as important to the economy and wider society as it is to the individual. The proposed health index not only measures how healthy people are today but also looks at the wider social and economic circumstances that will influence our – and the next generation’s – ability to live healthy lives in the future. Tracking these indicators over time provides the opportunity to finally look beyond GDP as a sole measure of national success.…

Read more of this article

Royal College of GPs and EDS toolkit

by Ehlers-Danlos Support UK

We were very disappointed to be told just before Christmas that the Royal College of GPs (RCGP) wanted to withdraw the Ehlers-Danlos syndromes (EDS) toolkit for GPs. The College planned to remove the toolkit from the RCGP website at the end of January. The RCGP cited pressure on its limited resources as a result of the pandemic and contention around the toolkit from various sources as reasons for its decision. While we understood that the College wanted to prioritise use of its resources, the move would have been a huge backwards step for people with EDS and related conditions.…

Read more of this article

NHFD Annual Report

The challenge of the next decade: are hip fracture services ready?

The National hip Fracture Database (NHFD) has recently released its latest annual report focussing on the six NHFD key performance indicators used to monitor and drive up standards across the country. 2020 will no doubt prove to be one of the most challenging years in the history of the NHS. This report also presents the first data about the effect of COVID-19 on trauma units around the country and on outcome for patients with hip fracture who have COVID-19 when admitted to hospital or develop it after their operation.…

Read more of this article

NICE to develop Interventional Procedures Guidance

NICE is developing Interventional Procedures Guidance: Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis IP1842.

Hip osteoarthritis can cause pain, stiffness and difficulty walking. Standard surgery to replace the joint (total hip arthroplasty) involves cutting tendons and muscles and pulling the hip joint apart to insert the new metal joint. In this procedure, a small cut is made in the skin (percutaneous). Muscles and tendons are moved apart to access the hip joint. A metal joint is inserted without fully pulling the hip joint apart (supercapsular).…

Read more of this article

RA disease not treated with advanced therapies

RA disease impact in patients not treated with advanced therapies; survey findings from the National Rheumatoid Arthritis Society

by NRAS

Recently NICE published a Final Appraisal Document in respect of a new JAK inhibitor (filgotinib –  Jyseleca) giving access to people with RA who have so called ‘moderate’ disease in addition to those with ‘severe’ disease. This is the first time NICE have broadened their eligibility criteria for access to advanced therapies and is warmly welcomed by NRAS. This comes at the same time as a paper published by the National Rheumatoid Arthritis Society (P.…

Read more of this article

COVID-19 vaccination and MSK

ARMA BSR BOA RAIRDA

Principles for COVID-19 Vaccination in Musculoskeletal and Rheumatology for Clinicians

(Version 12, 12 September 2022)

Amendment 12th September 2022: Document updated to include latest JCVI and NHSE guidance regarding autumn boosters using second generation bivalent COVID-19 vaccines and results of VROOM study (see section 23 and section 24 respectively)

Amendment 3rd April 2022: Document updated to include latest JCVI and NHSE guidance regarding spring 2022 boosters (see section 22)

Amendment 3rd December 2021: Document updated to include latest JCVI guidance regarding boosters for patients who were eligible for a third primary dose (see end of section 21)

Amendment 13 October 2021: Document updated to include revised BSR wording about third primary dose (section 20).

Read more of this article